Topics
Pediatric CNS tumors | Treatment | Targeted therapy | Selinexor
Home > Publications > Topics > Pediatric CNS tumors > Treatment > Targeted therapy > Selinexor
Green AL, Minard CG, Liu X, Safgren SL, Pinkney K, Harris L, Link
G, DeSisto J, Voss S, Nelson MD, Reid JM, Fox E, Weigel BJ, Glade
Bender J.
Phase 1 trial of selinexor
in pediatric recurrent/refractory solid and CNS tumors (ADVL1414):
A Children's Oncology Group Phase 1 Consortium Trial.
Clin
Cancer Res. 2025 Feb 25. doi:
10.1158/1078-0432.CCR-24-2754. PMID:
39998852. Observational study˰
ˍ